Pavan R.

Pavan R. has a robust background in the biomedical field, with significant roles spanning over two decades. Starting as a Master's degree thesis student at Central Drug Research Institute in 2002, Pavan R. progressed to a Production Officer at Shantha Biotechnics before serving as a Project Assistant at the Centre for Cellular and Molecular Biology. Academic achievements include a PhD in Biochemistry from Johann Wolfgang Goethe-Universität Frankfurt am Main. Pavan R. has held various prestigious positions, including Postdoctoral Fellow in Hematology/Oncology at Dana Farber/Boston Children's Cancer and Blood Disorders Center, Research Fellow at Harvard Medical School, and Senior Scientist in Early Drug Discovery Oncology at Skyhawk Therapeutics. Currently, Pavan R. serves as the Heme/Onc Translational Medicine/Biomarker Lead at AstraZeneca and continues to impact preclinical translation and cell biology as a Senior Scientist at Foghorn Therapeutics Inc. Prior experience also includes leading Discovery Biology as Principal Scientist at Disc Medicine and contributions to various research projects in oncology and signal transduction.